ACW Ann: FDA agrees to six-month Phase 2b Alzheimers Disease Trial - 22nd Dec 2022, 12:01pm

[annb0t]

ACW Ann: FDA agrees to six-month Phase 2b Alzheimers Disease Trial
Price Sensitive: Y
Date: 22nd Dec 2022, 12:01pm

>>> Read announcement: Google: ACW Market Announcements